Wikidata:Database reports/Constraint violations/P3636
Constraint violations report for PDB ligand ID (Discussion, uses, items, changes, related properties): identifier for small molecules and ligands in the Protein Data Bank (PDB)
Data time stamp: (UTC) — Items processed: 22,198
The report is generated based on the settings on Property:P3636#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
Data time stamp: (UTC) — Items processed: 22,198
The report is generated based on the settings on Property:P3636#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
"Unique value" violations
editViolations count: 12
- 2TN: atenolol (Q411325), (+)-atenolol (Q27095897)
- 8LX: lobeglitazone (Q18350076), (S)-lobeglitazone (Q27289613)
- BF0: β-funaltrexamine (Q27075143), methyl 4-{[(5beta,6alpha)-17-(cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]amino}-4-oxobutanoate (Q27458372)
- CCE: carbachol (Q419401), carbamoylcholine (Q27458733)
- HY0: hygromycin B (Q418735), hygromycin b variant (Q27461266)
- MG7: 7-methylguanosine ion (Q4642879), N7-methylguanosine (Q27260988)
- MZM: methazolamide (Q1149099), (Z)-methazolamide (Q27276292)
- NNA: narlaprevir (Q27254268), (1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-{(1S)-1-[(1R)-2-(cyclopropylamino)-1-hydroxy-2-oxoethyl]pentyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide (Q27463877)
- OCH: carbostyril (Q27095480), quinolin-2(1H)-one (Q74411364)
- P32: cyanopindolol (Q5197476), 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile (Q27097562)
- PH2: 2-amino-6-(hydroxymethyl)-7,8-dihydropteridin-4-ol (Q27093187), 6-Hydroxymethyl-7,8-dihydropterin (Q106570944)
- QNB: 3-quinuclidinyl-benzilate (Q223068), (3R)-1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate (Q27464767)
"Single value" violations
editViolations count: 144 (+ 1 exceptions)
- methane (Q37129): CH2, 74C
- L-aspartic acid (Q178450): ASP, IAS
- norepinephrine (Q186242): LNR, LT4
- levoleucovorin (Q192464): FFO, FOZ
- levomefolic acid (Q192553): C2F, THH
- 2-pyridone (Q209474): HRZ, T5Y
- acarbose (Q338005): QPS, PRD_900022
- L-selenocysteine (Q408663): SEC, CSE
- phytic acid (Q409679): I6P, IHP
- L-pyrrolysine (Q409687): PYL, PYH
- cytidine monophosphate (Q412622): C5P, C
- ribose 5-phosphate (Q418855): R5P, R52
- guanosine monophosphate (Q422473): 5GP, G25, G
- guanosine cyclic 3',5'-phosphate (Q422511): 35G, PCG
- uridine diphosphate glucose (Q424649): UPG, GUD
- echinenone (Q1280339): RAW, ECH
- deoxyadenosine 5'-monophosphate (Q1874427): D5M, DA
- L-tert-leucine (Q2405866): TBG, BUG
- deoxyuridine monophosphate (Q2741362): UMP, DU
- deoxycytidine dihydrogen phosphate (Q2742455): DCM, DC
- L-cysteine sulphinic acid (Q2823252): CSW, CSD
- aminoacetone (Q4545767): F3V, GLM
- 5'-Thymidylic acid (Q23905769): TMP, DT
- calcium(2+) (Q23905776): CA, DY
- L-glutamic acid (Q26995161): GLU, GGL
- L-(+)-methylenetetrahydrofolic acid (Q26995704): MHF, MEF
- 5'-UMP (Q27074278): U, U5P
- α,β-methylene adenosine 5'-diphosphate (Q27074395): A12, AP2
- D-glutamic acid (Q27077040): FGA, DGL
- GSK-J1 (Q27077924): K0I, URY
- L-βγ-meATP (Q27079196): ACP, ABG
- PP121 (Q27088428): 9HE, KS1
- SCH772984 (Q27088760): 38Z, F3Z
- 2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine (Q27093309): BMZ, 122
- 3,6,9,12,15-Pentaoxaheptadecane (Q27093357): P3G, 6JZ
- Leucine Phosphonic Acid (Q27093390): PLU, PLE
- 5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide (Q27093393): DA5, DAX
- ethylmercurithiosalicylic acid (Q27093682): T0M, EMT
- Pmp-Hydroxyisoxazole, Pyridoxamine-5-Phosphate-Hydroxyisoxazole (Q27094056): 7TS, PMH
- alpha-D-glucosamine 1-phosphate (Q27094063): GP1, L1L
- pteroic acid (Q27095023): PT1, 22D
- 2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE (Q27095760): 780, 130
- CRA_10950 (Q27096390): 950, 133
- [[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate (Q27096650): BA4, NP6
- [1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid (Q27096767): CCK, ATW
- 5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID (Q27096799): VAS, CPV
- (1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE (Q27097032): GD7, GD8
- N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE (Q27097298): L0F, L0H
- PHENYLALANYLMETHYLCHLORIDE (Q27097589): PHM, PCS
- 4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid (Q27097610): PIX, TF6
- 2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID (Q27097641): AY0, PTC
- 6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE (Q27097837): B7D, TRU
- 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID (Q27097841): TSA, TSO
- (2S,6S)-5,6,7,8-tetrahydrofolic acid (Q27098158): THG, THL
- guanosine 3'-diphosphate 5'-triphosphate (Q27102027): C1Z, 0O2
- prolinamide (Q27103084): 04V, LPD
- 5-guanidino-2-oxopentanoic acid (Q27103511): JX7, NWG
- L-α-aminobutyric acid (Q27104317): UNK, ABA
- digalacturonic acid (Q27104459): DG0, AD0
- 3'-deoxythymidine 5'-triphosphate (Q27104485): D3T, 23T
- N-(5'-phosphopyridoxyl)-L-alanine (Q27104538): PP3, PDA
- hexaethylene glycol (Q27104720): P2K, P6G
- N(3)-methyluridine 5'-monophosphate (Q27105026): 3MU, UR3
- tetra-mu3-sulfido-tetrairon(0) (Q27115702): ER2, 9S8
- 4-deoxy-Delta(4)-beta-D-GlcpA (Q27120438): GCD, DGC
- 1-(2-deoxy-5-O-phosphono-beta-L-ribofuranosyl)thymine (Q27120454): DRT, 0DT
- 2-hydroxy-dAMP (Q27132476): IGU, 0UH
- dodecanoyl-AMP (Q27157672): PBK, 1ZZ
- N-methyl-L-proline (Q27162479): PKR, 3BY
- ferrioxamine b (Q27259325): 0UE, BJ5
- benzylsulfonic acid (Q27261795): PMS, IOX
- surinamine (Q27273947): N9K, YNM
- lorlatinib (Q27285820): 53P, 5P8, QB4
- N6-(pyridoxal phosphate)lysine (Q27287328): IT1, LLP
- (4S,5S)-5-amino-4-hydroxy-6-phenylhexanoic acid (Q27449947): FOG, 0AC
- momo-2-[4-(2-(4-(methoxy)-1H-1,2,3-triazol-1-yl)ethyl)benzenesulfonamide]-7,12-bis-[3-(4-(methoxy)-1H-1,2,3-triazol-1-yl)propanoic acid]-cryptophane-a (Q27451013): 1CR, 0CR
- tert-butyl [(1S,2S)-1-benzyl-2-hydroxy-3-{[(8S,11R)-8-[(1R)-1-methylpropyl]-7,10-dioxo-2-oxa-6,9-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]amino}propyl]carbamate (Q27451048): PI6, 0EZ
- N~2~-phosphono-L-leucinamide (Q27451055): LEP, 0FA
- nalpha-[(4-methylpiperazin-1-yl)carbonyl]-N-[(3S)-1-phenyl-5-(phenylsulfonyl)pentan-3-yl]-L-phenylalaninamide (Q27451108): D1R, 0IW
- 2-{(2Z,5S)-4-hydroxy-2-[(2E)-(2-hydroxybenzylidene)hydrazinylidene]-2,5-dihydro-1,3-thiazol-5-yl}-N-[3-(trifluoromethyl)phenyl]acetamide (Q27451240): 9MZ, 0MZ
- N-[(4R)-4-ammonio-4-carboxybutanoyl]-L-cysteinylglycine (Q27451300): 0P0, GTT
- N-{(2R)-3-[(S)-[(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl]-2-benzylpropanoyl}-L-phenylalanine (Q27451315): PH0, 0PQ
- {4-[4-({3-[(2-methyl-1,3-benzothiazol-6-yl)amino]-3-oxopropyl}amino)-4-oxobutyl]benzyl}propanedioic acid (Q27451388): 0SN, 88N
- delta-ru(phen)2(dppz) complex (Q27451416): 0TN, RKP
- N-(4-{2-[(6S)-2-amino-4-oxo-1,4,5,6,7,8-hexahydropyrido[2,3-D]pyrimidin-6-yl]ethyl}benzoyl)-L-glutamic acid (Q27452646): L24, 21V
- 2'-aminouridine (Q27452848): 2AU, U2N
- methyl 3-isoxazol-5-yl-5-methyl-1H-pyrazole-4-carboxylate (Q27452901): 2D3, XQK
- tetrakis(2,2'-bipyridine-kappa~2~N~1~,N~1'~)(mu-tetrapyrido[3,2-a:2',3'-c:3'',2''-H:2''',3'''-j]phenazine-1kappa~2~N~4~,N~5~:2kappa~2~N~13~,N~14~)diruthenium(4+) L enantiomer (Q27452964): 2FJ, RUL
- (1R,2S,4S,5R)-2-(4-methoxyphenyl)methyl-1,4,5-trihydroxy-3-oxocyclohexane-1-carboxylic acid (Q27453732): 9ZT, 3DQ
- 1',2'-dideoxyribofuranose-5'-phosphate (Q27453733): 3DR, DN
- 5-nitro-1H-benzotriazole (Q27453965): 3NY, 6NT
- 5'-O-[(S)-hydroxy(methyl)phosphoryl]adenosine (Q27454412): ABM, 45A
- 3-amino-5-(pyrrolidin-1-yl)-1H-pyrazole-4-carbonitrile (Q27454456): 46X, E9Q
- (2R,4S,4as,5R)-6'-hydroxy-2,4-dimethyl-8-nitro-1,2,4,4a-tetrahydro-2'H,6H-spiro[1,4-oxazino[4,3-a]quinoline-5,5'-pyrimidine]-2',4'(3'H)-dione (Q27455372): 53M, 50M, 54Q, 53L
- (Z)-[(3R,4R,5R,6R)-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-ylidene]amino] N-phenylcarbamate (Q27455732): OGN, 5G0
- N-[1,1-bis(oxidanylidene)thian-4-yl]-5-methyl-4-oxidanylidene-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide (Q27456055): XZB, 5V2
- 5-(6-D-ribitylamino-2,4(1H,3H)pyrimidinedione-5-yl) pentyl-1-phosphonic acid (Q27456129): 5YL, INJ
- S-(3-methylbut-2-en-1-yl) trihydrogen thiodiphosphate (Q27456320): DST, 6C7
- N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methylpropyl]-4-methylbenzamide (Q27456449): MJQ, 6LX
- N6-methyl-deoxy-adenosine-5'-monophosphate (Q27456453): 6MC, 6MA
- 2'-O-methyl-5'-O-thiophosphonocytidine (Q27456493): OKQ, 6OO
- 4,6-dideoxy-4-amino-alpha-D-glucose (Q27457257): AGL, RV7
- methyl 2-(acetylamino)-3-O-[(1R)-1-carboxyethyl]-2-deoxy-beta-D-glucopyranoside (Q27457570): MMR, AMV
- N-(3-{[7-methoxy-6-(2-pyrrolidin-1-ylethoxy)quinazolin-4-yl]amino}-4-methylphenyl)-2-morpholin-4-ylisonicotinamide (Q27457845): AQZ, RNY
- carbonic acid monobenzyl ester (Q27458392): BGG, P6S
- 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose (Q27458568): BXP, XYB
- 2'-deoxy-5'-O-thiophosphonocytidine (Q27458687): SC, C7S, C7R
- (3S)-3,7-diaminoheptan-2-one (Q27458843): LYM, CKC
- trihydroxy-[(1S)-1-[[2-(phenylmethyl)phenyl]carbonylamino]ethyl]boron (Q27459803): EWB, E07
- 3'-deoxy-guanosine 5'-monophosphate (Q27460676): GDO, KAK
- 4-O-phosphono-D-glycero-beta-D-manno-heptopyranose (Q27460839): GPO, GPH
- (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid (Q27462052): KOL, MER
- (3ar,5R,6S,7R,7ar)-2-(ethylamino)-5-(hydroxymethyl)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-D][1,3]thiazole-6,7-diol (Q27463816): 8BJ, NHT
- 2,3,4,6-tetra-O-sulfohexopyranose (Q27463932): GU4, NT2
- (2R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid (Q27464364): PCZ, CEF
- 1-[2-(8-carbamoylmethyl-6,9-dioxo-2-oxa-7,10-diaza-bicyclo[11.2.2] heptadeca-1(16),13(17),14-trien-11-yl)-2-hydroxy-ethyl] -pyrrolidine-2-carboxylic acid [1-(1-carbamoyl-2-methyl-propylcarbamoyl) -2-methyl-butyl]-amide (Q27464430): 1ZR, PI1
- 4-phenyl-1H-imidazole (Q27464438): 231, PIM
- delta-[ru(bpy)2dppz]2+ (Q27464818): RLB, R1Z
- 2'-deoxy-adenosine-5'-rp-monomethylphosphonate (Q27465079): SMP, RMP
- uridine-5'-phosphorothioate (Q27465485): U37, SSU
- O-[(S)-amino(hydroxy)phosphoryl]-L-serine (Q27465507): SVW, SVV
- thymidine-5'-dithiophosphorate (Q27465698): THS, T2S
- 2-[3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-2-(1,2-dihydroxyethyl)-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl trihydrogen diphosphate (Q27466316): THD, 8N9
- (E)-isoeugenol (Q27889971): H7Y, EUG
- L-arginine(+) (Q28529679): ARG, GND
- deamido-NAD (Q28529688): DND, NXX
- L-Asparagine (Q29519883): 41Q, ASN
- (R)-1,2-distearoylphosphatidylethanolamine (Q60533035): PEH, 3PE
- NAD zwitterion (Q71535049): NAJ, NAD
- 5-Indazolamine (Q72482750): 8H4, 70S
- [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] dihydroxyphosphinothioyl hydrogen phosphate (Q76100175): SAP, AGS, ATG
- [(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(sulfooxymethyl)oxan-3-yl]sulfamic acid (Q76100646): SGN, YJM
- (3S)-5-fluoro-3-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoyl]amino]-4-oxopentanoic acid (Q76310355): F3G, 0PM
- 2-[2-[(1S)-1-aminoethyl]-4-methylidene-5-oxoimidazol-1-yl]acetic acid (Q76614896): MDO, CRW
- [(2R,3R,4R,5R)-3-hydroxy-4-methoxy-5-[4-(methylamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl dihydrogen phosphate (Q76617166): M4C, 4OC
- [(2R,3S,5R)-3-hydroxy-5-(6-methyl-2-oxo-7H-pyrrolo[2,3-d]pyrimidin-3-yl)oxolan-2-yl]methyl dihydrogen phosphate (Q76617168): 4PD, 4PC, 4PE
- 2-[(4Z)-2-[(1S)-1-aminoethyl]-4-[(4-hydroxyphenyl)methylidene]-5-oxoimidazol-1-yl]acetic acid (Q76617221): AYG, PIA
- (2S)-2-[[(2S)-2-amino-3-phenylpropyl]amino]-3-phenylpropanoic acid (Q76620361): PUK, FRF
- 2-[(4Z)-2-[(1R)-1-amino-2-hydroxyethyl]-4-[(4-hydroxyphenyl)methylidene]-5-oxoimidazol-1-yl]acetic acid (Q76620377): GYS, CSY
- [(1R,4S,6S)-6-hydroxy-4-(5-methyl-2,4-dioxopyrimidin-1-yl)cyclohex-2-en-1-yl]methyl dihydrogen phosphate (Q76620378): HDP, XTR
- (2R,4S,5R,6R)-5-acetamido-4-hydroxy-2-[4-[3-oxo-3-[2-[(2S,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ethylamino]propyl]triazol-1-yl]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid (Q76809908): 7BN, 7BO
- 3,5-Dimethylpyrazin-2(1H)-one (Q82383207): QOS, A1U
- BU72 (Q104668157): 4VO, VF1
- D-α-aminobutyric acid (Q113300938): DBB, AA3
"Format" violations
editViolations count: 1
"Conflicts with instance of (P31)" violations
editViolations count: 0
"Entity types" violations
editViolations count: 0
"Scope" violations
editViolations count: 0